159 related articles for article (PubMed ID: 36658634)
1. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes.
Zhang L; Lin Y; Li S; Guan X; Jiang X
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217089. PubMed ID: 36658634
[TBL] [Abstract][Full Text] [Related]
2. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer.
Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z
J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235
[TBL] [Abstract][Full Text] [Related]
4. Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression.
Azambuja JH; Ludwig N; Yerneni SS; Braganhol E; Whiteside TL
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32498400
[TBL] [Abstract][Full Text] [Related]
5. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
6. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
7. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
Kamerkar S; Leng C; Burenkova O; Jang SC; McCoy C; Zhang K; Dooley K; Kasera S; Zi T; Sisó S; Dahlberg W; Sia CL; Patel S; Schmidt K; Economides K; Soos T; Burzyn D; Sathyanarayanan S
Sci Adv; 2022 Feb; 8(7):eabj7002. PubMed ID: 35179953
[TBL] [Abstract][Full Text] [Related]
9. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
Kim H; Park HJ; Chang HW; Back JH; Lee SJ; Park YE; Kim EH; Hong Y; Kwak G; Kwon IC; Lee JE; Lee YS; Kim SY; Yang Y; Kim SH
Bioact Mater; 2023 Jul; 25():527-540. PubMed ID: 37056267
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity.
Zhong W; Lu Y; Han X; Yang J; Qin Z; Zhang W; Yu Z; Wu B; Liu S; Xu W; Zheng C; Schuchter LM; Karakousis GC; Mitchell TC; Amaravadi R; Flowers AJ; Gimotty PA; Xiao M; Mills G; Herlyn M; Dong H; Mitchell MJ; Kim J; Xu X; Guo W
Cell Rep; 2023 Oct; 42(10):113224. PubMed ID: 37805922
[TBL] [Abstract][Full Text] [Related]
11. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
12. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
14. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E.
Zheng P; Luo Q; Wang W; Li J; Wang T; Wang P; Chen L; Zhang P; Chen H; Liu Y; Dong P; Xie G; Ma Y; Jiang L; Yuan X; Shen L
Cell Death Dis; 2018 Apr; 9(4):434. PubMed ID: 29567987
[TBL] [Abstract][Full Text] [Related]
15. M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring α
Wu J; Gao W; Tang Q; Yu Y; You W; Wu Z; Fan Y; Zhang L; Wu C; Han G; Zuo X; Zhang Y; Chen Z; Ding W; Li X; Lin F; Shen H; Tang J; Zhang Y; Wang X
Hepatology; 2021 Apr; 73(4):1365-1380. PubMed ID: 32594528
[TBL] [Abstract][Full Text] [Related]
16. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
Guan H; Peng R; Fang F; Mao L; Chen Z; Yang S; Dai C; Wu H; Wang C; Feng N; Xu B; Chen M
J Cell Physiol; 2020 Dec; 235(12):9729-9742. PubMed ID: 32406953
[TBL] [Abstract][Full Text] [Related]
19. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
[TBL] [Abstract][Full Text] [Related]
20. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
